View of A comparative meta-analysis between Trastuzumab Deruxtecan (T-DXd) and Pertuzumab, trastuzumab, and docetaxel (PTD) in metastatic HER2-positive breast cancer

##article.return## A comparative meta-analysis between Trastuzumab Deruxtecan (T-DXd) and Pertuzumab, trastuzumab, and docetaxel (PTD) in metastatic HER2-positive breast cancer Download Download PDF